ASO Visual Abstract: Added Value of Radiotherapy Following Neoadjuvant FOLFIRINOX for Resectable and Borderline Resectable Pancreatic Cancer-A Systematic Review and Meta-analysis

Quisette P. Janssen, Jacob L. van Dam, Isabelle G. Kivits, Marc G. Besselink, Casper H. J. van Eijck, Marjolein Y. V. Homs, Joost J. M. E. Nuyttens, Hongchao Qi, Hjalmar J. van Santvoort, Alice C. Wei, Roeland F. de Wilde, Johanna W. Wilmink, Geertjan van Tienhoven, Bas Groot Koerkamp*

*Corresponding author for this work

Research output: Contribution to journalEditorialAcademicpeer-review

1 Citation (Web of Science)
Original languageEnglish
Pages (from-to)485-487
Number of pages3
JournalAnnals of Surgical Oncology
Volume28
Issue numberSUPPL 3
Early online dateJun 2021
DOIs
Publication statusPublished - Dec 2021

Bibliographical note

FUNDING:
This study is supported by the Dutch Cancer Society
(10955) and by ZonMw (843004108). No funding agency was
involved in the design of the study, or the collection, analysis, and
interpretation of data. The authors are solely responsible for the
content of the study and do not necessarily represent the viewpoint of
the Dutch Cancer Society or ZonMw.

Cite this